Sanofi (NASDAQ:SNY) Shares Acquired by Geneos Wealth Management Inc.

Geneos Wealth Management Inc. boosted its stake in shares of Sanofi (NASDAQ:SNY) by 9.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,063 shares of the company’s stock after purchasing an additional 582 shares during the period. Geneos Wealth Management Inc.’s holdings in Sanofi were worth $343,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Cardinal Capital Management raised its holdings in shares of Sanofi by 0.3% during the fourth quarter. Cardinal Capital Management now owns 58,854 shares of the company’s stock worth $2,927,000 after purchasing an additional 201 shares during the period. Daiwa Securities Group Inc. increased its holdings in shares of Sanofi by 3.4% in the 4th quarter. Daiwa Securities Group Inc. now owns 6,541 shares of the company’s stock valued at $325,000 after purchasing an additional 216 shares during the period. Wynn Capital LLC lifted its position in Sanofi by 4.5% in the 1st quarter. Wynn Capital LLC now owns 5,266 shares of the company’s stock worth $256,000 after buying an additional 226 shares in the last quarter. Angeles Investment Advisors LLC grew its holdings in shares of Sanofi by 2.1% during the 4th quarter. Angeles Investment Advisors LLC now owns 12,029 shares of the company’s stock valued at $598,000 after acquiring an additional 244 shares in the last quarter. Finally, Rise Advisors LLC grew its position in Sanofi by 98.4% in the fourth quarter. Rise Advisors LLC now owns 506 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Hedge funds and other institutional investors own 10.04% of the company’s stock.

Sanofi Trading Down 0.1 %

Shares of SNY stock opened at $51.14 on Friday. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $129.52 billion, a P/E ratio of 25.73, a price-to-earnings-growth ratio of 1.58 and a beta of 0.59. The firm’s fifty day simple moving average is $48.84 and its 200 day simple moving average is $48.64. Sanofi has a 1 year low of $42.63 and a 1 year high of $55.72.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.96. Sanofi had a return on equity of 26.25% and a net margin of 10.52%. The firm had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. As a group, sell-side analysts predict that Sanofi will post 4.14 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.